Titan Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	10	20.09	20	0	0	0
Revenue Growth (YoY)	-50.23%	0.47%	-	-	-	-
Gross Profit	10	20.09	20	0	0	0
Selling, General & Admin	10.67	12.43	7.63	7.82	3.33	3.01
Research & Development	37.35	37.96	7.94	51.42	32.86	12.9
Other Operating Expenses	0.45	0.7	0.28	0.03	3.51	2.97
Operating Expenses	48.47	51.08	15.85	59.27	39.69	18.88
Operating Income	-38.47	-30.99	4.15	-59.27	-39.69	-18.88
Interest Expense / Income	0.2	0.13	1.09	0.42	-0.29	-0.02
Other Expense / Income	-17.69	-16.31	27.24	-17.78	-16.76	14.72
Pretax Income	-20.99	-14.8	-24.18	-41.91	-22.64	-33.59
Income Tax	0.06	0.06	0	0	0	0
Net Income	-21.04	-14.86	-24.18	-41.91	-22.64	-33.59
Shares Outstanding (Basic)	112	111	67	31	17	8
Shares Outstanding (Diluted)	-	-	67	31	17	8
Shares Change	0.48%	65.84%	118.34%	84.49%	110.59%	-
EPS (Basic)	-0.18	-0.14	-0.36	-1.37	-1.36	-4.25
EPS (Diluted)	-0.18	-0.14	-0.36	-1.37	-1.36	-4.25
Free Cash Flow	-32.48	-36.99	-1.13	-45.96	-41.4	-19.09
Free Cash Flow Per Share	-0.29	-0.33	-0.02	-1.50	-2.49	-2.42
Gross Margin	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-384.74%	-154.22%	20.76%	-	-	-
Profit Margin	-210.43%	-73.95%	-120.92%	-	-	-
Free Cash Flow Margin	-324.82%	-184.08%	-5.63%	-	-	-
EBITDA	-19.93	-13.98	-22.81	-41.45	-22.9	-33.59
EBITDA Margin	-199.26%	-69.57%	-114.05%	-	-	-
Depreciation & Amortization	0.86	0.7	0.28	0.03	0.03	0.02
EBIT	-20.79	-14.68	-23.09	-41.48	-22.93	-33.6
EBIT Margin	-207.85%	-73.05%	-115.46%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).